Evidence map›Paper›PMID 34072606›Full record

ArticleInternational journal of molecular sciences2021

The Potential of Asiatic Acid in the Reversion of Cyclophosphamide-Induced Hemorrhagic Cystitis in Rats.

Andrzej Wróbel, Łukasz Zapała, Tomasz Kluz, Artur Rogowski, Marcin Misiek, Kajetan Juszczak, Jacek Sieńko, Daniela Gold, Klaudia Stangel-Wójcikiewicz, Ewa Poleszak and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
5.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Luteolin Improves Cyclophosphamide-Induced Cystitis through TXNIP/NLRP3 and NF-Evidence-based complementary and alternative medicine : eCAM · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 2 countries.

Andrzej WróbelSecond Department of Gynecology, Medical University of Lublin, Jaczewskiego 8, 20-090 Lublin, Poland.ORCID 0000-0002-5772-0573
Łukasz ZapałaClinic of General, Oncological and Functional Urology, Medical University of Warsaw, Lindleya 4, 02-005 Warsaw, Poland.ORCID 0000-0001-7340-280X
Tomasz KluzDepartment of Gynecology and Obstetrics, Institute of Medical Sciences, Medical College of Rzeszow University, 35-310 Rzeszow, Poland.
Artur RogowskiFaculty of Medicine, Collegium Medicum, Cardinal Stefan Wyszynski University in Warsaw, 01-938 Warsaw, Poland.ORCID 0000-0001-9184-1275
Marcin MisiekDepartment of Gynecologic Oncology, Holy Cross Cancer Center, 25-377 Kielce, Poland.
Kajetan JuszczakChair of Urology and Andrology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Skłodowskiej-Curie 9, 85-094 Bydgoszcz, Poland.
Jacek SieńkoSecond Department of Obstetrics and Gynecology, Medical University of Warsaw, 02-091 Warszawa, Poland.ORCID 0000-0002-6277-5237
Daniela GoldDepartment of Obstetrics and Gynecology, Medical University of Graz, Auenbruggerplatz, 8036 Graz, Austria.ORCID 0000-0002-7196-454X
Klaudia Stangel-WójcikiewiczDepartment of Gynecology and Oncology, Jagiellonian University Medical College, 31-501 Cracow, Poland.
Ewa PoleszakChair and Department of Applied and Social Pharmacy, Laboratory of Preclinical Testing, Medical University of Lublin, 1 Chodźki Street, 20-093 Lublin, Poland.ORCID 0000-0003-4359-3953
Piotr RadziszewskiClinic of General, Oncological and Functional Urology, Medical University of Warsaw, Lindleya 4, 02-005 Warsaw, Poland.
Medical University of Warsaw · PLMedical University of Lublin · PLCardinal Stefan Wyszynski University in Warsaw · PLHoly Cross University · PLJagiellonian University · PLMedical University of Graz · ATNicolaus Copernicus University · PLUniversity of Rzeszów · PL

Funding

Uniwersytet Medyczny w Lublinie Funds for Statutory Activity
6 · The paper itself

Abstract

The purpose of this study was to determine if asiatic acid may act efficiently in the model of cyclophosphamide (CYP)-induced cystitis in rats. We performed experiments after administration of CYP (single dose 200 mg/kg, intraperitoneally), asiatic acid (30 mg/kg/day for 14 consecutive days, by oral gavage), or CYP plus asiatic acid, during which conscious cystometry, measurements of urothelium thickness and bladder edema, as well as selected biomarkers analyses were conducted. In rats that received asiatic acid together with CYP, a drop in bladder basal pressure, detrusor overactivity index, non-voiding contraction amplitude, non-voiding contraction frequency, and the area under the pressure curve were observed, when compared to the CYP group. Furthermore, a significant increase in threshold pressure, voided volume, intercontraction interval, bladder compliance, and volume threshold to elicit NVC were found in that group accordingly. Administration of the asiatic acid successfully restored concentrations of biomarkers both in bladder urothelium (BDNF, CGRP, OCT-3, IL-1β, IL-6, NGF, nitrotyrosine, malondialdehyde, TNF-α, SV2A, SNAP23, SNAP25, PAC-1, ORM1, occludin, IGFBP-3, HB-EGF, T-H protein, Z01, and HPX) and detrusor muscle (Rho kinase and VAChT) in CYP-treated rats. Finally, asiatic acid significantly decreased urothelium thickness and bladder oedema. Asiatic acid proved to be a potent and effective drug in the rat model of CYP-induced cystitis.

Indexed as

AnimalsAntineoplastic Agents, AlkylatingBiomarkersCyclophosphamideCystitisDisease Models, AnimalHemorrhagePentacyclic TriterpenesRatsUrotheliumAntineoplastic Agents, Alkylatingasiatic acidBiomarkersCyclophosphamidePentacyclic Triterpenesasiatic acidcyclophosphamidehemorrhagic cystitis

Identifiers

PMID34072606
PMCPMC8198845
OpenAlexW3164179344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.